{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:44Z","timestamp":1790736344879,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2021-it25"],"award-info":[{"award-number":["lzujbky-2021-it25"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2018-it51"],"award-info":[{"award-number":["lzujbky-2018-it51"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107041"],"award-info":[{"award-number":["22107041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271307"],"award-info":[{"award-number":["32271307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["21JR11RA081"],"award-info":[{"award-number":["21JR11RA081"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["20JR5RA273"],"award-info":[{"award-number":["20JR5RA273"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.npep.2024.102440","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T22:53:59Z","timestamp":1718060039000},"page":"102440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects"],"prefix":"10.1016","volume":"107","author":[{"given":"Chenxi","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerine Peter","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2024.102440_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112788","article-title":"Novel virtual screening approach for the discovery of human tyrosinase inhibitors","volume":"9","author":"Ai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2024.102440_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjp.0706315","article-title":"Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine","volume":"146","author":"Bagley","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2024.102440_bb0015","doi-asserted-by":"crossref","first-page":"36944","DOI":"10.1074\/jbc.M112.382481","article-title":"Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors*","volume":"287","author":"Bauer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0020","series-title":"Molecular docking and dynamics studies to explore effective inhibitory peptides against the spike receptor binding domain of SARS-CoV-2","first-page":"8","author":"Biswas","year":"2022"},{"key":"10.1016\/j.npep.2024.102440_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.npep.2024.102440_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.154239","article-title":"Gram-scale preparation of DAMGO by typical solid phase synthesis","volume":"112","author":"Chen","year":"2022","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.npep.2024.102440_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.peptides.2004.10.026","article-title":"Antinociceptive action of hemopressin in experimental hyperalgesia","volume":"26","author":"Dale","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2024.102440_bb0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/prot.22927","article-title":"Salt bridges: geometrically specific, designable interactions","volume":"79","author":"Donald","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.npep.2024.102440_bb0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2024.102440_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.npep.2016.02.001","article-title":"Investigation of receptor binding and functional characteristics of hemopressin(1-7)","volume":"58","author":"Dvor\u00e1csk\u00f3","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2024.102440_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejmech.2019.05.037","article-title":"Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors","volume":"178","author":"Dvoracsko","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0060","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.npep.2024.102440_bb0065","doi-asserted-by":"crossref","first-page":"7254990","DOI":"10.1155\/2022\/7254990","article-title":"Molecular docking and molecular dynamics simulation of fisetin, galangin, hesperetin, hesperidin, myricetin, and naringenin against polymerase of dengue virus","volume":"2022","author":"Fatriansyah","year":"2022","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.npep.2024.102440_bb0070","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1096\/fj.09-132142","article-title":"Novel endogenous peptide agonists of cannabinoid receptors","volume":"23","author":"Gomes","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2024.102440_bb0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1208\/s12248-010-9217-x","article-title":"Hemoglobin-derived peptides as novel type of bioactive signaling molecules","volume":"12","author":"Gomes","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.npep.2024.102440_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2011.07.031","article-title":"Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain","volume":"1412","author":"Hama","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2024.102440_bb0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12954-023-00842-6","article-title":"An answered call for aid? Cannabinoid clinical framework for the opioid epidemic","volume":"20","author":"Hammaker","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.npep.2024.102440_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.113.209866","article-title":"Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(\u03b1)], an N-terminally extended hemopressin peptide","volume":"348","author":"Han","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2024.102440_bb0095","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jphp.12761","article-title":"Supraspinal inhibitory effects of chimeric peptide MCRT on gastrointestinal motility in mice","volume":"69","author":"He","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.npep.2024.102440_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.npep.2019.01.006","article-title":"In vitro and in vivo characterization of the bifunctional mu- and delta- opioid receptors ligand MCRT on mouse gastrointestinal motility","volume":"74","author":"He","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2024.102440_bb0105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bcpt.13566","article-title":"MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model","volume":"128","author":"He","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.npep.2024.102440_bb0110","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB 1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2024.102440_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108406","article-title":"Hemopressin as a breakthrough for the cannabinoid field","volume":"183","author":"Heimann","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2024.102440_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pcmedi\/pbab001","article-title":"Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs","volume":"4","author":"Hosseini","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.npep.2024.102440_bb0125","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.npep.2024.102440_bb0130","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/jm4005219","article-title":"Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance","volume":"56","author":"Le Naour","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2012.08.008","article-title":"Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide","volume":"179","author":"Li","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2024.102440_bb0140","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice: BN-9 produces nontolerance-forming antinociception","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2024.102440_bb0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/nmo.12789","article-title":"Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice","volume":"28","author":"Li","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.npep.2024.102440_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.106.106484","article-title":"Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of Endomorphin-1","volume":"319","author":"Liu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2024.102440_bb0155","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.npep.2024.102440_bb0160","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1021\/acs.jmedchem.8b01282","article-title":"Biodegradable amphipathic peptide hydrogels as extended-release system for opioid peptides","volume":"61","author":"Martin","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0165","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s13311-021-01069-8","article-title":"Pain relieving and neuroprotective effects of non-opioid compound, DDD-028, in the rat model of paclitaxel-induced neuropathy","volume":"18","author":"Micheli","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.npep.2024.102440_bb0170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/14756366.2016.1260565","article-title":"Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors","volume":"32","author":"Mollica","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0175","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1080\/07391102.2020.1842246","article-title":"Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation","volume":"40","author":"Mondal","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.npep.2024.102440_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/rapm-2020-102114","article-title":"Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians","volume":"46","author":"Narouze","year":"2021","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.npep.2024.102440_bb0185","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2174\/1389557520666200313120835","article-title":"The role of the cannabinoid system in opioid analgesia and tolerance","volume":"20","author":"Ozdemir","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0190","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2024.102440_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2014.06.058","article-title":"Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(\u03b1) and WIN55,212-2 at the supraspinal level in mice","volume":"578","author":"Pan","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2024.102440_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12864-018-4506-3","article-title":"Molecular dynamics simulations revealed structural differences among WRKY domain-DNA interaction in barley (Hordeum vulgare)","volume":"19","author":"Pandey","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.npep.2024.102440_bb0205","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid analgesia and opioid-induced adverse effects: a review","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.npep.2024.102440_bb0210","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1038\/s41598-017-09808-8","article-title":"Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage","volume":"7","author":"Petrucci","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.npep.2024.102440_bb0215","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0220","doi-asserted-by":"crossref","DOI":"10.3791\/3092-v","article-title":"The spared nerve injury (SNI) model of induced mechanical allodynia in mice","author":"Richner","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.npep.2024.102440_bb0225","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1074\/jbc.M212030200","article-title":"Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme","volume":"278","author":"Rioli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/phar.2115","article-title":"Cannabis for chronic pain: challenges and considerations","volume":"38","author":"Romero-Sandoval","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.npep.2024.102440_bb0235","doi-asserted-by":"crossref","first-page":"W611","DOI":"10.1093\/nar\/gkac305","article-title":"ProteinsPlus: a comprehensive collection of web-based molecular modeling tools","volume":"50","author":"Sch\u00f6ning-Stierand","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.npep.2024.102440_bb0240","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/07391102.2020.1815584","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","volume":"40","author":"Shivanika","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.npep.2024.102440_bb0245","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/acs.jmedchem.2c01695","article-title":"Multitargeted opioid ligand discovery as a strategy to retain analgesia and reduce opioid-related adverse effects","volume":"66","author":"Smith","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0250","article-title":"A conditioned place preference protocol for measuring incubation of craving in rats","volume":"58384","author":"Sun","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.npep.2024.102440_bb0255","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.npep.2024.102440_bb0260","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","article-title":"DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment","volume":"28","author":"Volkamer","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.npep.2024.102440_bb0265","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.npep.2024.102440_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2019.101998","article-title":"Signaling molecules targeting cannabinoid receptors: hemopressin and related peptides","volume":"79","author":"Wei","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2024.102440_bb0275","doi-asserted-by":"crossref","first-page":"108178","DOI":"10.1016\/j.neuropharm.2020.108178","article-title":"VF-13, a chimeric peptide of VD-hemopressin(\u03b1) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects","volume":"175","author":"Xu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2024.102440_bb0280","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1213\/ANE.0000000000006266","article-title":"OCP002, a mixed agonist of opioid and cannabinoid receptors, produces potent antinociception with minimized side effects","volume":"136","author":"Xu","year":"2023","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.npep.2024.102440_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109131","article-title":"Molecular docking and molecular dynamics simulation study the mechanism of progesterone in the treatment of spinal cord injury","volume":"188","author":"Yang","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.npep.2024.102440_bb0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.npep.2024.102440_bb0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2017.12.013","article-title":"CB(1) cannabinoid receptor agonist mouse VD-hemopressin(\u03b1) produced supraspinal analgesic activity in the preclinical models of pain","volume":"1680","author":"Zheng","year":"2018","journal-title":"Brain Res."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417924000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417924000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:55:45Z","timestamp":1726246545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417924000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"alternative-id":["S0143417924000398"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2024.102440","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2024.102440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102440"}}